ISS Wins DKK 300 Million Annual Deal to Manage Swiss Pharmaceutical Facilities
Zurich, Monday, 26 January 2026.
Transitioning from subcontractor to primary partner, ISS secures a mandate worth nearly DKK 300 million annually to deliver integrated services for a major Swiss life sciences company.
Elevating Partnership to Primary Status
In a strategic move that underscores the increasing demand for consolidated facility management in high-compliance sectors, ISS World Services A/S has announced a significant contract expansion with a major life sciences and pharmaceutical company in Switzerland [1]. The agreement, valued at approximately DKK 300 million annually, marks a pivotal evolution in the relationship between the two entities [1]. Previously operating as a subcontractor delivering selected services, ISS will transition to become the client’s direct and primary partner, assuming responsibility for a full spectrum of Integrated Facilities Services (IFS) across four distinct locations within Switzerland [1][4].
Scope of Services and Operational Timeline
The mandate, scheduled to commence in the second quarter of 2026, is set for an initial duration of three years, with an option to extend for an additional two years [1]. This expanded scope is comprehensive, covering critical technical services such as building inspections, repair and operations, as well as preventive and corrective maintenance [1]. Beyond technical support, the agreement encompasses a wide array of soft services including cleaning, grounds and winter maintenance, logistics, and postal services [4]. Crucially for the life sciences sector, the contract also includes specialized laboratory services and workplace support, all coordinated through a central customer helpdesk and on-site management [1].
Strategic Focus on Digital and Safe Environments
André Nauer, CEO of ISS Switzerland, characterized the deal as a major milestone built on a foundation of trust and operational collaboration [1]. The partnership aims to support the client’s broader purpose of advancing global health by ensuring safe, reliable, and future-ready work environments [1]. Nauer emphasized that the integrated approach will have innovative digital solutions at its core, highlighting the role of technology in modernizing facility management for complex industrial clients [1]. This contract win reinforces ISS’s strategy of deepening key accounts within the specialized pharmaceutical industry [1].